These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

844 related items for PubMed ID: 11207304

  • 1. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C, Goluszko E, Christadoss P.
    J Immunol; 2001 Mar 01; 166(5):3458-67. PubMed ID: 11207304
    [Abstract] [Full Text] [Related]

  • 2. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.
    Poussin MA, Tüzün E, Goluszko E, Scott BG, Yang H, Franco JU, Christadoss P.
    J Immunol; 2003 Apr 15; 170(8):4389-96. PubMed ID: 12682276
    [Abstract] [Full Text] [Related]

  • 3. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
    Zhang J, Bárdos T, Mikecz K, Finnegan A, Glant TT.
    J Immunol; 2001 Apr 15; 166(8):4981-6. PubMed ID: 11290777
    [Abstract] [Full Text] [Related]

  • 4. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
    Ostlie N, Milani M, Wang W, Okita D, Conti-Fine BM.
    J Immunol; 2003 Jan 01; 170(1):604-12. PubMed ID: 12496449
    [Abstract] [Full Text] [Related]

  • 5. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
    Aruna BV, Ben-David H, Sela M, Mozes E.
    Immunology; 2006 Jul 01; 118(3):413-24. PubMed ID: 16827902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells.
    Pál E, Tabira T, Kawano T, Taniguchi M, Miyake S, Yamamura T.
    J Immunol; 2001 Jan 01; 166(1):662-8. PubMed ID: 11123351
    [Abstract] [Full Text] [Related]

  • 15. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.
    Tüzün E, Scott BG, Goluszko E, Higgs S, Christadoss P.
    J Immunol; 2003 Oct 01; 171(7):3847-54. PubMed ID: 14500686
    [Abstract] [Full Text] [Related]

  • 16. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
    Wang W, Ostlie NS, Conti-Fine BM, Milani M.
    J Immunol; 2004 Jan 01; 172(1):97-103. PubMed ID: 14688314
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis by neglect of CD4+ Th cells in granulomas: a novel effector mechanism involved in the control of egg-induced immunopathology in murine schistosomiasis.
    Rutitzky LI, Mirkin GA, Stadecker MJ.
    J Immunol; 2003 Aug 15; 171(4):1859-67. PubMed ID: 12902487
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M, Oshima M, Atassi MZ, Christadoss P.
    Clin Immunol Immunopathol; 1993 Mar 15; 66(3):230-8. PubMed ID: 7679342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.